- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04135430
Parental Assessment of the Quality of Life of Infants With Bronchiolitis Episodes (BRONKILIB3)
Parental Assessment of the Quality of Life of Infants Under 12 Months of Age With Moderate Bronchiolitis Referred for Ambulatory Respiratory Physiotherapy
Infant bronchiolitis is a frequent pathology that is the cause of a very large number of medical outpatient and physiotherapy treatments in France. Many international studies and recommendations have invalidated any drug treatment during its management during the first episode. In France, the consensus conference promoted by the National Agency for Accreditation and Health Evaluation (ANAES) in September 2000 was in the same vein.
Regarding the respiratory physiotherapy component, posture drainage, vibration and percussion are not considered effective. ANAES recommended the use of respiratory physiotherapy with passive exhalation techniques. This is a method of care that has developed mainly in French-speaking countries, making it difficult to compare with the habits of Anglo-Saxon countries, which, more generally, do not prescribe it. In France, the level of evidence of its effectiveness is considered low (grade C). To date, the vast majority of studies have focused exclusively on a population of infants hospitalized for severe bronchiolitis. For this type of population, the value of such treatment to shorten the healing time has not been demonstrated. So much so that the ANAES, in its time, recommended that studies be carried out "on an outpatient basis" to assess their degree. In this respect, several recent studies have provided new data. Despite the reservations inherent in their methodologies and/or staff, they raise the question of the interest of the respiratory physiotherapy on an outpatient basis. In terms of professional practice, the American recommendations state that clinicians should educate family members about evidence-based diagnosis, treatment and prevention in bronchiolitis. Finally, an opinion survey concludes that holders of parental authority are seeking information on bronchiolitis and that approximately 90% have read the brochure given out of the maternity ward explaining the modes of transmission, manifestations, care and hygiene measures in the event of bronchiolitis. Pending new French recommendations, it seems legitimate to evaluate the level of perception of the effect of pediatric respiratory physiotherapy with increase in expiratory flow (IEF) in urban practice on the respiratory comfort of infants directly with families confronted with this pathology.
Study Overview
Detailed Description
Infant bronchiolitis is a frequent pathology that is the cause of a very large number of medical outpatient and physiotherapy treatments in France. Many international studies and recommendations have invalidated any drug treatment during its management during the first episode. In France, the consensus conference promoted by the National Agency for Accreditation and Health Evaluation (ANAES) in September 2000 was in the same vein.
Regarding the respiratory physiotherapy component, posture drainage, vibration and percussion are not considered effective. ANAES recommended the use of respiratory physiotherapy with passive exhalation techniques. This is a method of care that has developed mainly in French-speaking countries, making it difficult to compare with the habits of Anglo-Saxon countries, which, more generally, do not prescribe it. In France, the level of evidence of its effectiveness is considered low (grade C). To date, the vast majority of studies have focused exclusively on a population of infants hospitalized for severe bronchiolitis. For this type of population, the value of such treatment to shorten the healing time has not been demonstrated. So much so that the ANAES, in its time, recommended that studies be carried out "on an outpatient basis" to assess their degree. In this respect, several recent studies have provided new data. Despite the reservations inherent in their methodologies and/or staff, they raise the question of the interest of respiratory physiotherapy in ambulatory care. In terms of professional practice, the American recommendations state that clinicians should educate family members about evidence-based diagnosis, treatment and prevention in bronchiolitis. Finally, an opinion survey concludes that holders of parental authority are seeking information on bronchiolitis and that approximately 90% have read the brochure given out of the maternity ward explaining the modes of transmission, manifestations, care and hygiene measures in the event of bronchiolitis. Pending new French recommendations, it seems legitimate to evaluate the level of perception of the effect of pediatric respiratory physiotherapy with increase in expiratory flow (IEF) in urban practice on the respiratory comfort of infants directly with families confronted with this pathology.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Amiens, France
- Rb Picard
-
Annecy-le-Vieux, France
- RB 74
-
Arpajon, France
- GAB
-
Bordeaux, France
- Aquirespi
-
Fleury-les-Aubrais, France
- Rb Loiret
-
La Rochelle, France
- La Rochelle
-
Léguevin, France
- Occirespi
-
Malzéville, France
- Rb Grand Est
-
Marseille, France
- ARBAM
-
Paris, France
- CHU Robert-Debré
-
Seclin, France
- RB 59 62
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Infant up to 12 months of age
- Wang's score ≥ at 4 and < 9
- With first or second episode of bronchiolitis with a medical prescription for respiratory physiotherapy in the city.
- Consultation for a first session, or second session of respiratory physiotherapy
Exclusion Criteria:
- History or atopic predisposition
- History(s) of prematurity (34 weeks of amenorrhea or less)
- History of bronchopulmonary dysplasia
- Underlying heart disease, severe chronic lung disease
- Contraindication to the use of Kinesitherapy: prolonged corticosteroid therapy (more than one month), rickets, osteogenesis imperfecta, thrombocytopenia, rib fracture
- Opposition of holders of parental authority
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Survey
Practice of an updated questionnaire at D0, D2 and D7
|
practice of an updated questionnaire at D0, D2 and D7
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
QUALIN score
Time Frame: 24 hours
|
Evolution of the Quality of life of infants and young children (QUALIN) score between before the session and 12 to 24 hours after the session.
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaire about accessibility of the care chain
Time Frame: 8 days
|
This is a questionnaire that has not been validated in the literature.
Its purpose is to assess the feelings of holders of parental authority about the conditions of access to outpatient care.
|
8 days
|
|
Questionnaire about understanding of the information
Time Frame: 8 days
|
This is a questionnaire that has not been validated in the literature.
The purpose of this questionnaire is to evaluate the parent's feelings about understanding information
|
8 days
|
|
Questionnaire about perceived professional competence.
Time Frame: 8 days
|
This is a questionnaire that has not been validated in the literature.
The purpose of this questionnaire is to evaluate the parent's feelings about perceived professional competence
|
8 days
|
|
Questionnaire about security of care
Time Frame: 8 days
|
This is a questionnaire that has not been validated in the literature.
The purpose of this questionnaire is to evaluate the parent's feelings about perceived professional competence The security of care
|
8 days
|
|
Questionnaire about child's respiratory comfort
Time Frame: 8 days
|
This is a questionnaire that has not been validated in the literature.
The purpose of this questionnaire is to evaluate the parent's feelings about the evolution of their child's respiratory comfort after the physiotherapy session.
|
8 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BRONKILIB3
- 2019-A01633-54 (Other Identifier: ID-RCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchiolitis
-
Regend TherapeuticsShanghai Children's HospitalRecruitingPediatric Bronchiolitis ObliteransChina
-
Fondazione IRCCS Policlinico San Matteo di PaviaCompletedBronchiolitis Obliterans Syndrome (BOS)Italy
-
Hillel Yaffe Medical CenterCompletedReflexology | Bronchiolitis; ChemicalIsrael
-
University Hospital, Basel, SwitzerlandRecruitingBronchiolitis Obliterans Syndrome (BOS) | Bronchiolitis Obliterans (BO)Switzerland, Saudi Arabia
-
Seattle Children's HospitalPatient-Centered Outcomes Research Institute; Children's Hospital of PhiladelphiaRecruiting
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft vs Host Disease | Constrictive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
NYU Langone HealthTerminatedAcute BronchiolitisUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompletedSevere Viral BronchiolitisFrance
-
Hospices Civils de LyonCompleted
-
Guy's and St Thomas' NHS Foundation TrustCompletedAcute Viral BronchiolitisUnited Kingdom
Clinical Trials on Survey
-
Johns Hopkins Bloomberg School of Public HealthPontificia Universidad JaverianaCompletedNoncommunicable Diseases | Surveys and QuestionnairesColombia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Breast Carcinoma | Head and Neck CarcinomaUnited States
-
Weill Medical College of Cornell UniversityBoston Children's Hospital; Brigham and Women's Hospital; The Commonwealth FundCompletedPediatric ALLUnited States
-
Memorial Sloan Kettering Cancer CenterEnrolling by invitationSurvivors of Unilateral RetinoblastomaUnited States
-
Jaseng Medical FoundationCompletedFractures, Bone | Medicine, Korean TraditionalKorea, Republic of
-
M.D. Anderson Cancer CenterCompleted
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Université de Cergy PontoiseCompleted
-
Sarasota Memorial Health Care SystemEnrolling by invitation
-
Ohio State UniversityWithdrawnMedicare Part DUnited States